Pages that link to "Q44901652"
Jump to navigation
Jump to search
The following pages link to Osteopenia in adults with cystic fibrosis (Q44901652):
Displaying 50 items.
- Unique presentations and chronic complications in adult cystic fibrosis: do they teach us anything about CFTR? (Q21146746) (← links)
- Low bone mineral density in adults with cystic fibrosis (Q22299322) (← links)
- Cystic Fibrosis Adult Care (Q22306058) (← links)
- Osteoporosis in Canadian adult cystic fibrosis patients: a descriptive study (Q24800795) (← links)
- Normal bone mineral density in cystic fibrosis (Q28360933) (← links)
- Bone mineral status in 134 patients with cystic fibrosis (Q30753826) (← links)
- Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency (Q30870593) (← links)
- Current concepts in pediatric bone disease (Q31037297) (← links)
- UK reference data for the Hologic QDR Discovery dual-energy x ray absorptiometry scanner in healthy children and young adults aged 6-17 years (Q33255916) (← links)
- Vitamin d deficiency in cystic fibrosis (Q33635261) (← links)
- Rheumatic disease and cystic fibrosis (Q33710857) (← links)
- Comorbidities in end-stage lung disease (Q33755465) (← links)
- Osteoporosis: a new challenge in cystic fibrosis (Q33821308) (← links)
- A roadmap to the brittle bones of cystic fibrosis (Q34442832) (← links)
- Calcium metabolism, osteoporosis and essential fatty acids: a review (Q34471526) (← links)
- Bone mineral content in cystic fibrosis patients: correlation with fat-free mass (Q34798087) (← links)
- Whole body bone mineral content in healthy children and adolescents (Q35253937) (← links)
- Correlates of prepubertal bone mineral density in cystic fibrosis (Q35270791) (← links)
- Nutrient status of adults with cystic fibrosis (Q35506608) (← links)
- Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis (Q35506822) (← links)
- Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors (Q35534028) (← links)
- Treatment of premenopausal women with low bone mineral density (Q35551624) (← links)
- Musculoskeletal manifestations in cystic fibrosis (Q35561706) (← links)
- Management of osteoporosis in adults with cystic fibrosis (Q35626326) (← links)
- Hypervitaminosis D: case report of pediatric osteoporosis secondary to cystic fibrosis. (Q35755648) (← links)
- Transplantation osteoporosis (Q36658975) (← links)
- Expression of the mucosal vascular addressin, MAdCAM-1, in inflammatory liver disease (Q38466012) (← links)
- Nonpulmonary medical complications in the intermediate and long-term survivor (Q41502338) (← links)
- Management of complications of glucocorticoid therapy (Q41611539) (← links)
- Bone Mineral Density in Cystic Fibrosis Patients with the CFTR I1234V Mutation in a Large Kindred Family Is Associated with Pancreatic Sufficiency (Q42243097) (← links)
- Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease (Q44051284) (← links)
- Efficacy of Alendronate in Adults with Cystic Fibrosis with Low Bone Density (Q44620794) (← links)
- Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study (Q45044058) (← links)
- Prevalence of low bone mineral density in adolescents and adults with cystic fibrosis (Q46254121) (← links)
- Bone mineral density is related to lung function outcomes in young people with cystic fibrosis-A retrospective study (Q47693467) (← links)
- Role of exercise and nutrition status on bone mineral density in cystic fibrosis (Q47917810) (← links)
- Volumetric bone mineral density in children with cystic fibrosis (Q50891968) (← links)
- Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation (Q50966154) (← links)
- Factors associated with low bone mineral density in patients with cystic fibrosis (Q51153556) (← links)
- Bone densitometry should be included in the evaluation of candidates for lung transplantation. (Q53527792) (← links)
- Metabolic bone disease in gut diseases. (Q54679743) (← links)
- Post heart/lung transplantation management. (Q55351069) (← links)
- Osteoporosis in lung transplantation candidates with end-stage pulmonary disease (Q56638117) (← links)
- Bone mineral density in lung-transplant recipients before and after graft: prevention of lumbar spine post-transplantation-accelerated bone loss by pamidronate (Q63370893) (← links)
- Bone density in children and adolescents with cystic fibrosis (Q70873060) (← links)
- Nutritional management of cystic fibrosis (Q71137797) (← links)
- Osteopenia in adults with cystic fibrosis (Q71596783) (← links)
- Allergic bronchopulmonary aspergillosis as presenting sign of cystic fibrosis in an elderly man (Q74102242) (← links)
- Osteoporosis after organ transplantation (Q74645498) (← links)
- Osteoporosis in adults with cystic fibrosis (Q77111277) (← links)